Pfizer (PFE) Shares Outstanding (2016 - 2022)
Historic Shares Outstanding for Pfizer (PFE) over the last 13 years, with Q2 2022 value amounting to $9.5 billion.
- Pfizer's Shares Outstanding rose 51.88% to $9.5 billion in Q2 2022 from the same period last year, while for Apr 2022 it was $9.5 billion, marking a year-over-year increase of 51.88%. This contributed to the annual value of $9.5 billion for FY2021, which is 68.03% up from last year.
- Latest data reveals that Pfizer reported Shares Outstanding of $9.5 billion as of Q2 2022, which was up 51.88% from $9.5 billion recorded in Q4 2021.
- In the past 5 years, Pfizer's Shares Outstanding registered a high of $9.5 billion during Q2 2022, and its lowest value of $9.3 billion during Q2 2018.
- For the 5-year period, Pfizer's Shares Outstanding averaged around $9.4 billion, with its median value being $9.4 billion (2020).
- In the last 5 years, Pfizer's Shares Outstanding surged by 33.1% in 2020 and then soared by 69.17% in 2021.
- Quarter analysis of 5 years shows Pfizer's Shares Outstanding stood at $9.3 billion in 2018, then grew by 0.4% to $9.4 billion in 2019, then rose by 0.41% to $9.4 billion in 2020, then rose by 0.68% to $9.5 billion in 2021, then increased by 0.24% to $9.5 billion in 2022.
- Its Shares Outstanding was $9.5 billion in Q2 2022, compared to $9.5 billion in Q4 2021 and $9.5 billion in Q4 2021.